47 research outputs found

    Using the Social-Local-Mobile App for Smoking Cessation in the SmokeFreeBrain Project: Protocol for a Randomized Controlled Trial

    Get PDF
    Objective: We present a study protocol of a 12-month randomized open-label parallel-group trial whose primary objective is to analyze the efficacy and efficiency of usual psychopharmacological therapy plus the Social-Local-Mobile app (intervention group) applied to the smoking cessation process compared with usual psychopharmacological therapy alone (control group). Methods: The target population consists of adult smokers (both male and female) attending the Smoking Cessation Unit at Virgen del Rocío University Hospital, Seville, Spain. Social-Local-Mobile is an innovative intervention based on mobile technologies and their capacity to trigger behavioral changes. The app is a complement to pharmacological therapies to quit smoking by providing personalized motivational messages, physical activity monitoring, lifestyle advice, and distractions (minigames) to help overcome cravings. Usual pharmacological therapy consists of bupropion (Zyntabac 150 mg) or varenicline (Champix 0.5 mg or 1 mg). The main outcomes will be (1) the smoking abstinence rate at 1 year measured by means of exhaled carbon monoxide and urinary cotinine tests, and (2) the result of the cost-effectiveness analysis, which will be expressed in terms of an incremental cost-effectiveness ratio. Results: Of 548 patients identified using the hospital's electronic records system, we excluded 308 patients: 188 declined to participate and 120 did not meet the inclusion criteria. A total of 240 patients were enrolled: the control group (n=120) will receive usual psychopharmacological therapy, while the intervention group (n=120) will receive usual psychopharmacological therapy plus the So-Lo-Mo app. Conclusions: Social networks and mobile technologies influence our daily lives and, therefore, may influence our smoking habits as well.The research study is funded by H2020 European Commission project (Grant Agreement 681120), as part of the SmokeFreeBrain project. Further information about the project can be found on the SmokeFreeBrain project website (www.smokefreebrain.eu)

    Association of Killer Cell Immunoglobulin-Like Receptor Genes with Hodgkin's Lymphoma in a Familial Study

    Get PDF
    BACKGROUND: Epstein-Barr virus (EBV) is the major environmental factor associated with Hodgkin's lymphoma (HL), a common lymphoma in young adults. Natural killer (NK) cells are key actors of the innate immune response against viruses. The regulation of NK cell function involves activating and inhibitory Killer cell Immunoglobulin-like receptors (KIRs), which are expressed in variable numbers on NK cells. Various viral and virus-related malignant disorders have been associated with the presence/absence of certain KIR genes in case/control studies. We investigated the role of the KIR cluster in HL in a family-based association study. METHODOLOGY: We included 90 families with 90 HL index cases (age 16–35 years) and 255 first-degree relatives (parents and siblings). We developed a procedure for reconstructing full genotypic information (number of gene copies) at each KIR locus from the standard KIR gene content. Out of the 90 collected families, 84 were informative and suitable for further analysis. An association study was then carried out with specific family-based analysis methods on these 84 families. PRINCIPAL FINDINGS: Five KIR genes in strong linkage disequilibrium were found significantly associated with HL. Refined haplotype analysis showed that the association was supported by a dominant protective effect of KIR3DS1 and/or KIR2DS1, both of which are activating receptors. The odds ratios for developing HL in subjects with at least one copy of KIR3DS1 or KIR2DS1 with respect to subjects with neither of these genes were 0.44[95% confidence interval 0.23–0.85] and 0.42[0.21–0.85], respectively. No significant association was found in a tentative replication case/control study of 68 HL cases (age 18–71 years). In the familial study, the protective effect of KIR3DS1/KIR2DS1 tended to be stronger in HL patients with detectable EBV in blood or tumour cells. CONCLUSIONS: This work defines a template for family-based association studies based on full genotypic information for the KIR cluster, and provides the first evidence that activating KIRs can have a protective role in HL

    ATLID, ESA Atmospheric LIDAR Developement Status

    No full text
    The ATmospheric LIDAR ATLID[1] is part of the payload of the Earth Cloud and Aerosol Explorer[2] (EarthCARE) satellite mission, the sixth Earth Explorer Mission of the European Space Agency (ESA) Living Planet Programme. EarthCARE is a joint collaborative satellite mission conducted between ESA and the National Space Development Agency of Japan (JAXA) that delivers the Cloud Profiling Radar (CPR) instrument. The payload consists of four instruments on the same platform with the common goal to provide a picture of the 3D-dimensional spatial and the temporal structure of the radiative flux field at the top of atmosphere, within the atmosphere and at the Earth’s surface. This paper is presenting an updated status of the development of the ATLID instrument and its subsystem design. The instrument has recently completed its detailed design, and most of its subsystems are already under manufacturing of their Flight Model (FM) parts and running specific qualification activities. Clouds and aerosols are currently one of the biggest uncertainties in our understanding of the atmospheric conditions that drive the climate system. A better modelling of the relationship between clouds, aerosols and radiation is therefore amongst the highest priorities in climate research and weather prediction

    ATLID, ESA Atmospheric LIDAR Developement Status

    No full text
    The ATmospheric LIDAR ATLID[1] is part of the payload of the Earth Cloud and Aerosol Explorer[2] (EarthCARE) satellite mission, the sixth Earth Explorer Mission of the European Space Agency (ESA) Living Planet Programme. EarthCARE is a joint collaborative satellite mission conducted between ESA and the National Space Development Agency of Japan (JAXA) that delivers the Cloud Profiling Radar (CPR) instrument. The payload consists of four instruments on the same platform with the common goal to provide a picture of the 3D-dimensional spatial and the temporal structure of the radiative flux field at the top of atmosphere, within the atmosphere and at the Earth’s surface. This paper is presenting an updated status of the development of the ATLID instrument and its subsystem design. The instrument has recently completed its detailed design, and most of its subsystems are already under manufacturing of their Flight Model (FM) parts and running specific qualification activities. Clouds and aerosols are currently one of the biggest uncertainties in our understanding of the atmospheric conditions that drive the climate system. A better modelling of the relationship between clouds, aerosols and radiation is therefore amongst the highest priorities in climate research and weather prediction

    JSFlow

    No full text

    Empathic autonomous agents

    No full text
    Identifying and resolving conflicts of interests is a key challenge when designing autonomous agents. For example, such conflicts often occur when complex information systems interact persuasively with humans and are in the future likely to arise in non-human agent-to-agent interaction. We introduce a theoretical framework for an empathic autonomous agent that proactively identifies potential conflicts of interests in interactions with other agents (and humans) by considering their utility functions and comparing them with its own preferences using a system of shared values to find a solution all agents consider acceptable. To illustrate how empathic autonomous agents work, we provide running examples and a simple prototype implementation in a general-purpose programing language. To give a high-level overview of our work, we propose a reasoning-loop architecture for our empathic agent
    corecore